TG6002
AXP000094.1 · Oncolytic virus
- Platform
- vaccinia virus (Copenhagen, TK- RR-)
- Originator
- Transgene
- Sponsor
- Transgene
Names
Virus
- Role
- Oncolytic
- Family
- Poxviridae
- Virus
- vaccinia virus (NCBI Taxonomy 10245)
- Strain
- Copenhagen
- Replication
- conditionally replicating
- Modifications
- J2R (thymidine kinase) and I4L (ribonucleotide reductase large subunit) deleted
- Transgenes
- FCU1
- Route
- intravenous, intratumoral, intra arterial
- Source
- evidence
Cross-references
- NCI Thesaurus
- C148178
Approvals
No regulatory approval recorded.
Clinical trials (4)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT04194034 | Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer | Terminated | Phase 1/2 | 2020-01-17 | 2023-02-23 | 15 | Colorectal Neoplasms |
| NCT04226066 | Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors | Unknown | Phase 1/2 | 2019-11-20 | 2021-05-31 | 69 | Advanced Malignant Solid Tumors |
| NCT03724071 | Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. | Terminated | Phase 1/2 | 2018-10-16 | 2023-02-23 | 51 | Colorectal Neoplasm; Digestive System Neoplasm |
| NCT03294486 | Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients | Unknown | Phase 1/2 | 2017-10-12 | 2019-05 | 78 | Brain Cancer; Glioblastoma |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 39785814 | A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2025 | name in title: TG6002 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41070126 | TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma. | Frontiers in microbiology | 2025 | name in title: TG6002 |
| PMID 38806994 | A viral attack on brain tumors: the potential of oncolytic virus therapy. | Journal of neurovirology | 2024 | name in abstract: TG6002 |
| PMID 37635744 | Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors. | Molecular therapy oncolytics | 2023 | name in title: TG6002 |
| PMID 34004331 | Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme. | Seminars in cancer biology | 2022 | name in abstract: TG6002 |
| PMID 34915313 | T598 and T601 phosphorylation sites of canine parvovirus NS1 are crucial for viral replication and pathogenicity. | Veterinary microbiology | 2022 | name in title: T601 |
| PMID 33500518 | Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs. | Scientific reports | 2021 | name in title: TG6002 |
| PMID 32843040 | Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs. | BMC veterinary research | 2020 | name in title: TG6002 |
| PMID 33072863 | Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer. | Molecular therapy oncolytics | 2020 | name in title: TG6002 |
| PMID 31011628 | The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism. | Molecular therapy oncolytics | 2019 | name in title: TG6002 |
| PMID 28496337 | Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes. | OncoTargets and therapy | 2017 | name in title: TG6002 |
Unconfirmed matches (11)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 32060423 | PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression. | Oncogene | 2020 | name in abstract: T601 |
| PMID 25982914 | Genotype-specific prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in Asian countries. | International journal of antimicrobial agents | 2015 | name in abstract: T601 |
| PMID 23118474 | Phenotypic and molecular characterization of Staphylococcus aureus recovered from different clinical specimens of inpatients at a teaching hospital in Shanghai between 2005 and 2010. | Journal of medical microbiology | 2013 | name in abstract: T601 |
| PMID 21239868 | Distribution of virulence genes in spa types of methicillin-resistant Staphylococcus aureus isolated from patients in intensive care units. | The Korean journal of laboratory medicine | 2011 | name in abstract: T601 |
| PMID 20510060 | [Research on genotyping of methicillin-resistant Staphylococcus aureus in China.]. | Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi | 2010 | name in abstract: T601 |
| PMID 19685173 | Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter. | Pharmaceutical research | 2009 | name in abstract: T601 |
| PMID 8407585 | Studies on cell growth stimulating substances of low molecular weight. Part 2. Exfoliazone and lavanducyanin, potent growth promoting substances of rat liver cell line, RLN-8, produced by Streptomyces exfoliatus and Streptomyces aeriouvifer. | The Journal of antibiotics | 1993 | name in abstract: T601 |
| PMID 3032185 | Conservation of E6 and E7 regions of human papillomavirus types 16 and 18 present in cervical cancers. | Biochemical and biophysical research communications | 1987 | name in abstract: T601 |
| PMID 6181731 | Correlation between D region structure and antigen-binding specificity: evidences from the comparison of closely related immunoglobulin VH sequences. | Annales d'immunologie | 1981 | name in abstract: T601 |
| PMID 6772205 | A common mechanism of hapten binding to immunoglobulins and their heterologous chain recombinants. | Biochemistry | 1980 | name in abstract: T601 |
| PMID 804990 | A new, mouse-myeloma immunoglobulin A having specificity for beta-D-(1 yields 6)-linked D-galactopyranosyl residues. | Carbohydrate research | 1975 | name in abstract: T601 |
Notes
Armed with the yeast FCU1 gene, used with oral flucytosine. Licensed to Tasly Biopharmaceuticals for China, where it is called T601 (NCIt lists T601 as a synonym of TG6002), so T601 is recorded here as the same program and not a separate one.
How to cite
TG6002 (AXP000094.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000094.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.